Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TYMS | P04818 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KCNJ1 | P48048 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | NSD2 | O96028 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29504833 | 1.00 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL854575 | 0.78 | KCNJ1 (0.46) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL15546074 | 0.76 | MAPT (0.40) | MAOBMAOATYMSALDH1A1HSD17B10 | |
| SCHEMBL32672785 | 0.75 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL78594 | 0.75 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL30991499 | 0.75 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL856025 | 0.75 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL698199 | 0.75 | PIM1 (0.48) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL2045834 | 0.75 | MAOB (0.47) | MAOBMAOAKDM4ETYMSALDH1A1 | |
| SCHEMBL7639394 | 0.75 | KCNJ1 (0.51) | MAOBMAOAKDM4ETYMSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136797-A | Full continuous flow preparation method of quizalofop-p-ethyl | 浙江工业大学 | 2025-06-13 | — | — | CN | claimed |
| CN-114755316-B | Method for screening dangerous substances in food contact material and application | 广州质量监督检测研究院 | 2024-02-27 | — | — | CN | claimed |
| US-20260116879-A1 | AZAINDOLE ROCK INHIBITORS | AVICENNA BIOSCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | SUMITOMO PHARMA AMERICA, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4642764-A2 | AZAINDOLE ROCK INHIBITORS | Avicenna Biosciences, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12415805-B2 | Azaindole rock inhibitors | AVICENNA BIOSCIENCES, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250250273-A1 | AZAINDOLE ROCK INHIBITORS | AVICENNA BIOSCIENCES, INC. (US) | 2025-08-07 | — | — | US | disclosed |
| US-12286433-B1 | Azaindole rock inhibitors | AVICENNA BIOSCIENCES, INC. (US) | 2025-04-29 | — | — | US | disclosed |
| US-12281115-B2 | Azaindole rock inhibitors | AVICENNA BIOSCIENCES, INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250115605-A1 | AZAINDOLE ROCK INHIBITORS | AVICENNA BIOSCIENCES, INC. (US) | 2025-04-10 | — | — | US | disclosed |
| US-20250092038-A1 | AZAINDOLE ROCK INHIBITORS | AVICENNA BIOSCIENCES, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| US-7541489-B2 | Method of making halophthalic acids and halophthalic anhydrides | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-06-02 | — | — | US | disclosed |
| US-20080275211-A1 | METHOD OF MAKING HALOPHTHALIC ACIDS AND HALOPHTHALIC ANHYDRIDES | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2008-11-06 | — | — | US | disclosed |
| EP-1773747-A1 | METHOD OF MAKING HALOPHTHALIC ACIDS AND HALOPHTHALIC ANHYDRIDES | General Electric Company (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006004822-A1 | METHOD OF MAKING HALOPHTHALIC ACIDS AND HALOPHTHALIC ANHYDRIDES | GENERAL ELECTRIC COMPANY (US) | 2006-01-12 | — | — | WO | disclosed |
| US-20060004224-A1 | Method of making halophthalic acids and halophthalic anhydrides | GENERAL ELECTRIC COMPANY | 2006-01-05 | — | — | US | disclosed |
| US-20060004223-A1 | Method of making halophthalic acids and halophthalic anhydrides | GENERAL ELECTRIC COMPANY | 2006-01-05 | — | — | US | disclosed |
| EP-1375468-A2 | Method for removing impurities from oxidation products | GENERAL ELECTRIC COMPANY (US) | 2004-01-02 | — | — | EP | disclosed |
| US-6670487-B1 | Of ortho-dimethylbenzene compounds; phthalic acid and phthalic anhydride by oxidation of ortho-xylene; extracting solution of aromatic anhydride product with an aqueous bicarbonate to hydrolyze the anhydride to the acid | GENERAL ELECTRIC COMPANY | 2003-12-30 | — | — | US | disclosed |
| US-4244966-A | 1,3-Dihydro-3-(2-hydroxy-, 2-bromo- or 2-chloroethyl)-2H-isoindol-1-one derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415805-B2 | Azaindole rock inhibitors | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
| US-20060004223-A1 | Method of making halophthalic acids and halophthalic anhydrides | HAO2, HPD, HAAO | MAOB 488/4885MAOA 533/4885KDM4E 3423/4885 |
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ADH1C, HTR6, CNR1 | MAOB 37/4885MAOA 57/4885KDM4E 2475/4885 |
| US-20250250273-A1 | AZAINDOLE ROCK INHIBITORS | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
| US-12281115-B2 | Azaindole rock inhibitors | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
| US-20260116879-A1 | AZAINDOLE ROCK INHIBITORS | PRKG2, PRKG1, ROCK2 | MAOB 1428/4885MAOA 875/4885KDM4E 637/4885 |
| US-20250115605-A1 | AZAINDOLE ROCK INHIBITORS | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
| US-20060004224-A1 | Method of making halophthalic acids and halophthalic anhydrides | HAO2, HPD, HAAO | MAOB 525/4885MAOA 627/4885KDM4E 3171/4885 |
| US-12286433-B1 | Azaindole rock inhibitors | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
| US-20080275211-A1 | METHOD OF MAKING HALOPHTHALIC ACIDS AND HALOPHTHALIC ANHYDRIDES | HAO2, HPD, HAAO | MAOB 525/4885MAOA 627/4885KDM4E 3171/4885 |
| US-20250092038-A1 | AZAINDOLE ROCK INHIBITORS | ROCK2, ROCK1, ARHGDIA | MAOB 2468/4885MAOA 2497/4885KDM4E 494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.